These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [ Viitanen R; Virtanen H; Liljenbäck H; Moisio O; Li XG; Nicolini V; Richard M; Klein C; Nayak T; Jalkanen S; Roivainen A Front Immunol; 2022; 13():901693. PubMed ID: 35874707 [TBL] [Abstract][Full Text] [Related]
10. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice. Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944 [TBL] [Abstract][Full Text] [Related]
11. (68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections. Ahtinen H; Kulkova J; Lindholm L; Eerola E; Hakanen AJ; Moritz N; Söderström M; Saanijoki T; Jalkanen S; Roivainen A; Aro HT EJNMMI Res; 2014; 4():45. PubMed ID: 25520903 [TBL] [Abstract][Full Text] [Related]
12. Safety Study of Single-Dose Intravenously Administered DOTA-Siglec-9 Peptide in Sprague Dawley Rats. Chrusciel P; Yatkin E; Li XG; Jaakkola UM; Knuuti J; Jalkanen S; Roivainen A Int J Toxicol; 2019; 38(1):4-11. PubMed ID: 30663453 [TBL] [Abstract][Full Text] [Related]
13. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma. Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of (68)Ga-labeled Siglec-9 peptide for the imaging of acute lung inflammation: a pilot study in a porcine model of acute respiratory distress syndrome. Retamal J; Sörensen J; Lubberink M; Suarez-Sipmann F; Borges JB; Feinstein R; Jalkanen S; Antoni G; Hedenstierna G; Roivainen A; Larsson A; Velikyan I Am J Nucl Med Mol Imaging; 2016; 6(1):18-31. PubMed ID: 27069763 [TBL] [Abstract][Full Text] [Related]
15. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Aalto K; Autio A; Kiss EA; Elima K; Nymalm Y; Veres TZ; Marttila-Ichihara F; Elovaara H; Saanijoki T; Crocker PR; Maksimow M; Bligt E; Salminen TA; Salmi M; Roivainen A; Jalkanen S Blood; 2011 Sep; 118(13):3725-33. PubMed ID: 21821708 [TBL] [Abstract][Full Text] [Related]
16. Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques. Silvola JM; Virtanen H; Siitonen R; Hellberg S; Liljenbäck H; Metsälä O; Ståhle M; Saanijoki T; Käkelä M; Hakovirta H; Ylä-Herttuala S; Saukko P; Jauhiainen M; Veres TZ; Jalkanen S; Knuuti J; Saraste A; Roivainen A Sci Rep; 2016 Oct; 6():35089. PubMed ID: 27731409 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of experimental BT4C glioma models for somatostatin receptor 2-targeted therapies. Kiviniemi A; Gardberg M; Autio A; Li XG; Heuser VD; Liljenbäck H; Käkelä M; Sipilä H; Kurkipuro J; Ylä-Herttuala S; Knuuti J; Minn H; Roivainen A Acta Oncol; 2014 Aug; 53(8):1125-34. PubMed ID: 24957558 [TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement. Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338 [TBL] [Abstract][Full Text] [Related]
20. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]